Retatrutide and Tirzepatide from ₱750 a vial in 25, 50 and 100 packs. Split it with friends or resell it under your own label.From ₱750 a vial: 25, 50 and 100 packs for group buys and resellers. See bulk prices →

Skin and hair · Compound

SNAP-8

Topical cosmetic octapeptide (Acetyl Octapeptide-3) modelled on the SNAP-25 protein, studied in manufacturer and in vitro work for expression wrinkles.

Philippines Peptides editorial deskUpdated Trial data checked 23 September 20265 min read3 sources

SNAP-8 is not yet in the evidence datasets this site draws on, so this page makes no claim about what it does.

What is SNAP-8

SNAP-8 (Acetyl Octapeptide-3) is an octapeptide (8 amino acid chain) designed to mimic the N-terminal end of the SNAP-25 protein. SNAP-25 is one of the proteins involved in neurotransmitter release at the neuromuscular junction, the connection between nerve endings and muscle fibers, as set out in the 2013 Neuron review cited below. Browse the full peptide library for related skin compounds.

The manufacturer's technical datasheet describes SNAP-8 as a botulinum-mimetic peptide and a competitive inhibitor of SNAP-25, and a 2012 review of cosmetic botulinum-mimetic peptides covers it alongside acetyl hexapeptide-3. That evidence is cosmetic and in vitro; no phase 2 or phase 3 human trial is cited on this page, and SNAP-8 is not in the evidence datasets this site draws on.

SNAP-8 is sold as an ingredient in topical serums and creams, not as an injectable. GHK-Cu is a separate peptide with its own guide.

How it works

SNAP-25 competition: in the manufacturer's in vitro data, SNAP-8 competes with the body's own SNAP-25 protein for a place in the SNARE complex, the protein assembly that fuses vesicles with the nerve membrane before acetylcholine is released (SNARE mechanism per the 2013 Neuron review).

Proposed effect on wrinkles: the manufacturer and the 2012 review describe reduced contraction force in facial expression muscles as the proposed route to softer expression wrinkles. That route rests on cosmetic and in vitro studies, not on a controlled clinical trial.

Benefits studied

SNAP-8 is not yet in the evidence datasets this site draws on, so this page makes no claim about what it does. Anything published about it elsewhere should be read with its evidence level in mind: most peptides in this category have animal or cell data only.

Side effects reported

No controlled human data on adverse events for SNAP-8 is in the datasets this site draws on, so its safety in people is unknown rather than established. Effects commonly described for it are listed below; how often they occur has not been measured in a controlled trial.

  • Mild skin irritation
  • Temporary redness in sensitive skin
  • Contact dermatitis
  • Irritation when layered with other active topicals such as retinol or AHAs (theoretical)

Regulatory status

The regulatory dataset this site draws on has no row for SNAP-8.

Who should not use SNAP-8

Everything above is research framing. If you have got as far as wanting a vial, the catalogue at Primara Labs, our partner and supplier, is the shortest way to see what is held inside the Philippines and at what price. View the Primara Labs catalogue

FAQ

How does SNAP-8 differ from botulinum toxin?

SNAP-8 is described in its sources as a botulinum-mimetic peptide: it is applied to the skin and is proposed, on manufacturer and in vitro data, to act on the same SNAP-25 step of nerve signalling that botulinum toxin acts on, by competing with SNAP-25. No trial comparing SNAP-8 with botulinum toxin is cited on this page.

Is SNAP-8 the same as Argireline?

No. Argireline is acetyl hexapeptide-3, a six-amino-acid peptide. SNAP-8 is acetyl octapeptide-3, an eight-amino-acid peptide. The 2012 review cited on this page covers both as botulinum-mimetic cosmetic peptides.

What evidence exists for SNAP-8?

SNAP-8 is not in the evidence datasets this site draws on. The sources on this page are a manufacturer technical datasheet (Lipotec), a 2012 review of botulinum-mimetic cosmetic peptides in Clinical, Cosmetic and Investigational Dermatology, and a 2013 Neuron review of the neurotransmitter-release mechanism. The evidence type is cosmetic and in vitro; no phase 2 or phase 3 human trial is cited.

Where to get SNAP-8 in the Philippines

Primara Labs, our partner and supplier, lists their current vials on the catalogue. Prices and stock change, so check there for what is available now. View the Primara Labs catalogue

The supply index covers what to ask a seller before paying, and why quoted prices vary so widely.

View Supply Index

Primary sources

Citations supporting the clinical claims on this page. Each entry links to the primary record.

All 3 sources: Lipotec / Centerchem SNAP-8 mechanism: SNAP25 inhibition, Acetyl hexapeptide / octapeptide cosmetic anti-wrinkle review, SNARE complex / SNAP-25 mechanism: Sudhof Nobel review

  1. Lipotec / Centerchem SNAP-8 mechanism: SNAP25 inhibitionReference

    Lipotec / The Lubrizol Corporation. "SNAP-8 (Acetyl Octapeptide-3) Technical Datasheet: botulinum-mimetic peptide, SNAP-25 competitive inhibitor."

    Source

  2. Acetyl hexapeptide / octapeptide cosmetic anti-wrinkle reviewReview

    Reddy BY et al. "Botulinum-mimetic peptides for cosmetic dermatology: a review of acetyl hexapeptide-3 and acetyl octapeptide-3 evidence." Clin Cosmet Investig Dermatol. 2012;5:7–12.

    PMID: 22334965

  3. SNARE complex / SNAP-25 mechanism: Sudhof Nobel reviewMechanism

    Sudhof TC. "Neurotransmitter release: the last millisecond in the life of a synaptic vesicle." Neuron. 2013;80(3):675-690.

    DOI: 10.1016/j.neuron.2013.10.022

Risk · Disclosure · Editorial Status

This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician (ideally one with peptide-specific clinical experience) before starting any compound, adjusting a dose, or discontinuing therapy.

In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.

Editorial Status
Non-clinical
Affiliation
Not a clinic · Not a pharmacy
Last Updated
September 24, 2026

Related peptides

Updated